Telephone sharing button Contact Us linkedin sharing button Share wechat sharing button Share wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Manufacturing

 

WuXi Biologics operates multiple state-of-the-art, premier quality cGMP drug substance and drug product facilities across four countries. Our current GMP drug substance manufacturing capacity is over 90,000 L (150,000 L by the close of 2021) and growing to 430,000 L across five countries after 2024. We currently maintain 9 drug product facilities capable of conducting liquid or lyophilized fills at varying clinical and commercial scales and utilizing a variety of container and closure configurations. For more information click on the following drug substance and drug product manufacturing links.